SENSING-AI in Patients With Long COVID (SENSING-AI)
SENSING-AI
Retrospective Data Collection for SENSING-AI: a Wearable Platform for the Early Diagnosis of Emotional Disorders and Exacerbations in Patients With Long COVID Through the Use of Artificial Intelligence
1 other identifier
observational
103
1 country
1
Brief Summary
The retrospective study will be used to develop an artificial intelligence model of risk stratification of physiological and psychological complications arising from the information available in the electronic medical record and first consultation report to support patients and healthcare professionals in better managing the healthcare process for patients diagnosed with long COVID.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2022
CompletedFirst Submitted
Initial submission to the registry
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedFebruary 18, 2025
February 1, 2024
1 month
January 31, 2024
February 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective SENSING-AI cohort
The retrospective SENSING-AI cohort will be fed from clinical information of 100 cases of patients with long COVID-19.
1 month
Study Arms (1)
Retrospective Long COVID cases
The target population will be as balanced as possible between subjects who needed specialized care due to long COVID-19 complications (either specialized care consultations or any non-planned hospital admission) at 1 month, 3 months, 6 months and 1 year from the long COVID-19 diagnose and those who did not require such specialized care.
Interventions
There will be a review of available clinical data sources related to use cases. In addition, this information will be complemented by a cohort of anonymized retrospective data of 100 cases obtained from the clinical information resulting from the assistance to COVID-19 patients managed by the Primary Care Health District of Sevilla Norte and the Infectious Diseases Department of the Virgen Macarena University Hospital
Eligibility Criteria
The sample size for the retrospective study enough to generate a first version of the risk stratification models will be around 100 cases. The target population will be as balanced as possible between subjects who needed specialized care due to long COVID-19 complications (either specialized care consultations or any non-planned hospital admission) at 1 month, 3 months, 6 months and 1 year from the long COVID-19 diagnose and those who did not require such specialized care.
You may qualify if:
- Legal adult
- Diagnosed of long COVID-19 in the last year
- With the presence of any of these symptoms:
- Asthenia (Tiredness)
- Dyspnea
- Shortness of breath
- Anxiety
- Stress
- Depression
- Sleep disorder
You may not qualify if:
- Attended to specialized care consultation
- Was admitted in hospital in the last year due to a problem not related to the COVID complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Adhera Health, Inc.lead
- Hospital Universitario Virgen Macarenacollaborator
Study Sites (1)
Virgen Macarena University Hospital
Seville, Seville, 41009, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2024
First Posted
February 7, 2024
Study Start
January 18, 2022
Primary Completion
February 25, 2022
Study Completion
February 25, 2022
Last Updated
February 18, 2025
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share